![Aclaris Therapeutics](https://i0.wp.com/www.mychesco.com/wp-content/uploads/2020/03/Aclaris-Therapeutics-1.jpg?resize=735%2C400&ssl=1)
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results, Provides a Corporate Update
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced its financial results for the third quarter of 2023 and provided a corporate update.
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results, Provides a Corporate Update Read More